• Clinical Evidence

Implementation of Glucose Management Software (EndoTool) Intra-Operatively in Cardiac Surgery Patients to Improve Post-Operative Blood Glucose Control and Compliance with SCIP INF-4

Setting: 1,018-bed academic medical center and Level 1 trauma center.

Objective

This retrospective study compares SCIP-Inf-4 compliance with use of EndoTool solely for post-operative glucose management to SCIP-Inf-4 compliance with use of EndoTool for both intra- and post-operative glucose management.

Setting

1,018-bed academic medical center and Level 1 trauma center.

Results

  • Percentage of patients in full SCIP-Inf-4 compliance increased from 80.5% to 89.4% with use of EndoTool for both intra- and post-operative glucose management.
  • Percentage of patients in SCIP-Inf-4 compliance post-operative Day 1 increased from 91.7% to 98.5% with use of EndoTool for both intra- and post-operative glucose management.
  • Among patients in SCIP-Inf-4 compliance post-operative Day 1 but not post-operative Day 2, all (100%) had been discontinued from EndoTool prior to the 6:00 am blood glucose check.

Conclusions

Use of EndoTool for both intra- and post-operative glucose management of cardiac surgery patients leads to improved SCIP-Inf-4 compliance (a program that aims to decrease incidence of surgical site infections) over use of EndoTool solely for post-operative glucose management; however, early discontinuation of patients from EndoTool prior to the post-operative Day 2 6:00 am blood glucose check has a negative effect on SCIP-Inf-4 compliance.

Objective

This retrospective study compares SCIP-Inf-4 compliance with use of EndoTool solely for post-operative glucose management to SCIP-Inf-4 compliance with use of EndoTool for both intra- and post-operative glucose management.

Setting

1,018-bed academic medical center and Level 1 trauma center.

Results
  • Percentage of patients in full SCIP-Inf-4 compliance increased from 80.5% to 89.4% with use of EndoTool for both intra- and post-operative glucose management.
  • Percentage of patients in SCIP-Inf-4 compliance post-operative Day 1 increased from 91.7% to 98.5% with use of EndoTool for both intra- and post-operative glucose management.
  • Among patients in SCIP-Inf-4 compliance post-operative Day 1 but not post-operative Day 2, all (100%) had been discontinued from EndoTool prior to the 6:00 am blood glucose check.
Conclusions

Use of EndoTool for both intra- and post-operative glucose management of cardiac surgery patients leads to improved SCIP-Inf-4 compliance (a program that aims to decrease incidence of surgical site infections) over use of EndoTool solely for post-operative glucose management; however, early discontinuation of patients from EndoTool prior to the post-operative Day 2 6:00 am blood glucose check has a negative effect on SCIP-Inf-4 compliance.

References

Authors

Michael Denaburg, PharmD; Earnest Alexander, PharmD, FCCM; Maresa Glass, PharmD, BCPS; Ren Chen, MD, MPH.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 40, Issue 12, p1-328.

Year

2013

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective study compares SCIP-Inf-4 compliance with use of EndoTool solely for post-operative glucose management to SCIP-Inf-4 compliance with use of EndoTool for both intra- and post-operative glucose management.

Setting

1,018-bed academic medical center and Level 1 trauma center.

Results
  • Percentage of patients in full SCIP-Inf-4 compliance increased from 80.5% to 89.4% with use of EndoTool for both intra- and post-operative glucose management.
  • Percentage of patients in SCIP-Inf-4 compliance post-operative Day 1 increased from 91.7% to 98.5% with use of EndoTool for both intra- and post-operative glucose management.
  • Among patients in SCIP-Inf-4 compliance post-operative Day 1 but not post-operative Day 2, all (100%) had been discontinued from EndoTool prior to the 6:00 am blood glucose check.
Conclusions

Use of EndoTool for both intra- and post-operative glucose management of cardiac surgery patients leads to improved SCIP-Inf-4 compliance (a program that aims to decrease incidence of surgical site infections) over use of EndoTool solely for post-operative glucose management; however, early discontinuation of patients from EndoTool prior to the post-operative Day 2 6:00 am blood glucose check has a negative effect on SCIP-Inf-4 compliance.

References

Authors

Michael Denaburg, PharmD; Earnest Alexander, PharmD, FCCM; Maresa Glass, PharmD, BCPS; Ren Chen, MD, MPH.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 40, Issue 12, p1-328.

Year

2013

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.